October 17, 2025

2025 American Academy of Ophthalmology Annual Meeting

Topics cover practice management, interventional glaucoma, amniotic membranes, and more.

October 16, 2025

Nordic Pharma to Feature Lacrifill, New Data at AAO

Nordic Pharma, Inc. will feature Lacrifill Canalicular Gel, as well as recently published Lacrifill patient data and patient experience study results with attendees at AAO.

November 01, 2024

An Update on SLT Clinical Trials

The ongoing COAST trial hopes to answer the question of which selective laser trabeculoplasty treatment approach is most effective.

November 01, 2024

Regeneron Leaders Recognized for Innovation at Eyecelerator 2024

Drs. Schleifer and Yancopoulos received the Eyecelerator Innovation Award and discussed the long and winding road to success.

November 01, 2024

An Update on SLT Clinical Trials

The ongoing COAST trial hopes to answer the question of which selective laser trabeculoplasty treatment approach is most effective.

November 01, 2024

Regeneron Leaders Recognized for Innovation at Eyecelerator 2024

Drs. Schleifer and Yancopoulos received the Eyecelerator Innovation Award and discussed the long and winding road to success.

October 23, 2024

Laser Beats Drops in Slowing Glaucoma

October 01, 2024

Addressing Sustainability in Ophthalmology

A discussion on reducing waste and costs in your surgical and clinical practice.

October 01, 2024

Study Presented at AAO 2024 Highlights Waste of Eyedrops

A study presented at AAO highlights the cost and environmental impact of clinics disposing of eyedrops long before their expiration dates.

October 01, 2024

Study Presented at AAO 2024 Highlights Waste of Eyedrops

A study presented at AAO highlights the cost and environmental impact of clinics disposing of eyedrops long before their expiration dates.

October 01, 2024

Paul Hahn, MD, PhD, Discusses Physician Reimbursement at AAO

During Retina Subspecialty Day at AAO 2024, Paul Hahn, MD, PhD, discussed recent studies that examined the financial impact of step therapy and inflation on reimbursement for retinal physicians. The studies were conducted by the Health Economics Committee of the American Society of Retina Specialists.

October 01, 2024

Addressing Sustainability in Ophthalmology

A discussion on reducing waste and costs in your surgical and clinical practice.

October 01, 2024

Paul Hahn, MD, PhD, Discusses Physician Reimbursement at AAO

During Retina Subspecialty Day at AAO 2024, Paul Hahn, MD, PhD, discussed recent studies that examined the financial impact of step therapy and inflation on reimbursement for retinal physicians. The studies were conducted by the Health Economics Committee of the American Society of Retina Specialists.

October 01, 2024

Eylea HD Data Discussion With Drs. Kaiser and Do at AAO

Peter K. Kaiser, MD, and Diana Do, MD, discuss 3-year data from the PHOTON trial for diabetic macular edema at the 2024 American Academy of Ophthalmology meeting.

October 01, 2024

Pegcetacoplan an Effective Treatment for Subfoveal GA

Three-year data from the GALE open-label extension study, presented at AAO, demonstrated an anatomical and visual function benefit of continuous pegcetacoplan treatment for patients with subfoveal geographic atrophy.

October 01, 2024

New Analysis of LiGHT Finds SLT Significantly Slows Glaucoma Progression Compared to Drops

Laser slows glaucoma progression by 29% compared with topicals, researchers at Moorfields show.

October 01, 2024

Fellow Eye Dosing of Gene Therapy Found Safe, Effective

Data from a recently completed study, presented at the American Academy of Ophthalmology meeting in Chicago, indicates that a subretinal gene therapy in development for neovascular (“wet”) age-related macular degeneration (nAMD) is both safe and effective when dosed bilaterally.

October 01, 2024

Transformative Strategies in Ocular Oncology Presented at AAO 2024

Evolving approaches to treatment, and advancements in identifying and treating ocular melanomas, have greatly improved patient survival rates and quality of life.

October 01, 2024

The Top Five Ophthalmic Provider Strategy Initiatives for ROI

"While there are certainly more than five initiatives these days, we have isolated those we have experienced in active advisory services. They are without question of regular, almost daily, concern," said Max Reiboldt, CPA.

October 01, 2024

Scleral Buckling: Let There Be Light

The chandelier scleral buckle procedure, using radial or segmental sponge explants, offers better visualization, reducing complications and improving outcomes.

October 01, 2024

New Analysis of LiGHT Finds SLT Significantly Slows Glaucoma Progression Compared to Drops

Laser slows glaucoma progression by 29% compared with topicals, researchers at Moorfields show.

October 01, 2024

Transformative Strategies in Ocular Oncology Presented at AAO 2024

Evolving approaches to treatment, and advancements in identifying and treating ocular melanomas, have greatly improved patient survival rates and quality of life.

October 01, 2024

One Simple Trick to Increase Sustainability in Your Clinic — and Save Money

Researchers found that approximately 72% of medication was still in the bottles when they were discarded.

October 01, 2024

Faricimab Effective in Underrepresented DME Patients

Data from the ELEVATUM trial, presented at AAO, indicates that Hispanic and Black patients with diabetic macular edema responded well to treatment with faricimab.

October 01, 2024

Fellow Eye Dosing of Gene Therapy Found Safe, Effective

Data from a recently completed study, presented at the American Academy of Ophthalmology meeting in Chicago, indicates that a subretinal gene therapy in development for neovascular (“wet”) age-related macular degeneration (nAMD) is both safe and effective when dosed bilaterally.